From food to supplements and toys, Big County Raw has everything you need to get your best friend through the holiday season. You can find them in 1800 locations across the country, or order ...

He has pledged to take on Big Pharma in the role ... Ballreich and Weissman worry that Kennedy’s support of raw milk, vitamins, and disproven treatments for Covid-19, including ivermectin ...

The researchers found that administering 75 grams of vitamin C three times a week doubled overall survival rates of patients with late-stage metastatic pancreatic cancer from eight months to 16 ...

Researchers at the University of Michigan's Rogel and Blondy Pancreatic Cancer Center are believed to be the first in the world to study the pancreases of organ donors, giving unique insight into ...

After four grueling and highly competitive weeks of playoff football, only the Big Country’s most elite teams on the gridiron are left standing in the 2024 Texas high school football playoffs.

As the Texas high school basketball season starts to shift into gear in December, it’s time to assess the Big Country’s high school girls basketball scene. Following a wild 2023-24 season ...

The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer (NSCLC) or pancreatic cancer. The drug is the first comprehensive ...

The story, told in eight episodes, covers different facets of the American Spirit, from racial and religious tolerance to the dangers of self-centeredness and myopic reasoning. The parables ...

Key eligibility criteria were patients age 18 years or older and had undergone complete macroscopic resection for ductal adenocarcinoma of the pancreas. Country of participation and resection margin ...

A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...

Bizengri received FDA approval for NSCLC and pancreatic adenocarcinoma with NRG1 gene fusion after prior therapy failure. The eNRGy study showed a 33% ORR in NSCLC and 40% in pancreatic adenocarcinoma ...